Acrivon Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACRV and other ETFs, options, and stocks.

About ACRV

Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3).

CEO

Peter Blume-Jensen

CEOPeter Blume-Jensen

Employees

Employees78

Headquarters

Watertown, Massachusetts

HeadquartersWatertown, Massachusetts

Founded

2018

Founded2018

Employees

Employees78

ACRV Key Statistics

Market cap

37.78M

Market cap37.78M

Price-Earnings ratio

-0.54

Price-Earnings ratio-0.54

Dividend yield

—

Dividend yield—

Average volume

482.51K

Average volume482.51K

High today

$1.34

High today$1.34

Low today

$1.20

Low today$1.20

Open price

$1.29

Open price$1.29

Volume

1.82M

Volume1.82M

52 Week high

$10.16

52 Week high$10.16

52 Week low

$1.05

52 Week low$1.05

Analyst ratings

89%

of 9 ratings

Buy

88.9%

Hold

11.1%

Sell

People also own

Based on the portfolios of people who own ACRV. This list is generated using Robinhood data, and it’s not a recommendation.

Iovance Biotherapeutics